Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation: Cardiovascular Imaging
Search: search_blue_button Advanced Search
Circulation: Cardiovascular Imaging. 2009;2:405-411
Published online before print July 8, 2009, doi: 10.1161/CIRCIMAGING.108.832113
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2/5/405    most recent
CIRCIMAGING.108.832113v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Whitehead, K. K.
Right arrow Articles by Rome, J. J.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Whitehead, K. K.
Right arrow Articles by Rome, J. J.
Related Collections
Right arrow Cardiovascular imaging agents/Techniques
Right arrow CT and MRI
Right arrow CV surgery: other
Right arrow Pediatric and congenital heart disease, including cardiovascular surgery

Original Articles

Noninvasive Quantification of Systemic-to-Pulmonary Collateral Flow

A Major Source of Inefficiency in Patients With Superior Cavopulmonary Connections

Kevin K. Whitehead, MD, PhD; Matthew J. Gillespie, MD; Matthew A. Harris, MD; Mark A. Fogel, MD and Jonathan J. Rome, MD

From the Division of Cardiology, Children’s Hospital of Philadelphia, Philadelphia, Pa.

Correspondence to Kevin K. Whitehead, MD, PhD, Cardiology, 8th Floor Main Bldg, 8NW71, Children’s Hospital of Philadelphia, Philadelphia, PA 19104. E-mail whiteheadk{at}email.chop.edu

Received November 10, 2008; accepted July 7, 2009.

Background— Systemic-to-pulmonary collateral flow (SPCF) is common in single-ventricle patients with superior cavopulmonary connections (SCPC). Because no validated method to quantify SPCF exists, neither its hemodynamic burden nor its clinical impact can be systematically evaluated. We hypothesize that (1) the difference in total ascending aortic (Ao) and caval flow (superior vena cava [SVC]+inferior vena cava [IVC]) and (2) the difference between pulmonary vein and pulmonary artery flow (PV–PA) provide 2 independent estimators of SPCF.

Methods and Results— We measured Ao, SVC, IVC, right (RPA) and left (LPA) PA, and left (LPV) and right (RPV) PV flows in 17 patients with SCPC during routine cardiac MRI studies using through-plane phase-contrast velocity mapping. Two independent measures of SPCF were obtained: model 1, Ao–(SVC+IVC); and model 2, (LPV–LPA)+(RPV–RPA). Values were normalized to body surface area, Ao, and PV, and comparisons were made using linear regression and Bland-Altman analysis. SPCF ranged from 0.2 to 1.4 L/min for model 1 and 0.2 to 1.6 L/min for model 2, for an average indexed SPCF of 0.5 to 2.8 L/min/m2: 11% to 53% (mean, 37%) of Ao and 19% to 77% (mean, 54%) of PV. The mean difference between model 1 and model 2 was 0.01 L/min (P=0.40; 2-SD range, –0.45 to 0.47 L/min).

Conclusions— We present a noninvasive method for SPCF quantification in patients with SCPC. It should provide an important clinical tool in treating these patients. Furthermore, we show that SPCF is a significant hemodynamic burden in many patients with bidirectional Glenn shunt physiology. Future investigations will allow objective study of the impact of collateral flow on outcome.

Key Words: single ventricle • collateral circulation • MRI • blood flow • superior cavopulmonary connection


 

CLINICAL PERSPECTIVE